Target intelligence / Profile preview

Blood circulation promotion via multi-herbal synergy in TCM theory

Molecular classification
Other
01

Overview

"Blood circulation promotion via multi-herbal synergy in TCM theory" is a traditional Chinese medicine therapeutic concept, not a single molecule, receptor, or gene. It refers to the use of multiple herbs—each with different mechanisms—to synergistically improve blood circulation, reduce blood stasis (obstruction/sluggishness of blood), and treat related disorders such as cardiovascular diseases, diabetes complications, and vascular dysfunction. While mechanism studies have identified endpoints such as antiplatelet activity, vasorelaxation, endothelial protection, and Na⁺/K⁺-ATPase inhibition, this therapeutic principle is not reducible to any one molecular target[1][3][4][5]. Rather, it encompasses a polypharmacological, system-level intervention characteristic of TCM formulations. This entry does not map to a canonical drug target and should be flagged as improper or non-specific for structured target data.

Other names
Blood circulation activation (TCM)Blood stasis removal (TCM)Huoxue Huayu (活血化瘀)TCM blood-moving therapy
02

Mechanism of action

Antiplatelet aggregation (e.g., inhibition of TXA₂/PGI₂ imbalance); Vasodilation; Protection of vascular endothelium and basement membrane; Inhibition of Na⁺/K⁺-ATPase (through steroid-like compounds); Modulation of calcium signaling in myocardium; Inhibition of advanced glycation end-product formation; Antioxidant and lipid-lowering effects

03

Biological functions

Blood flow regulationHemorheology modulationAntiplatelet activityVascular protectionOther
04

Disease associations

Cardiovascular diseaseDiabetes complicationsMicrovascular diseaseThrombosisAtherosclerosisOther
05

Safety considerations

Herb-drug interactions (e.g., additive antiplatelet effect)Bleeding risk when combined with anticoagulantsVariability in herbal compound potency/qualityNull (no molecule-specific or receptor-specific toxicities)
06

Interacting drugs

Salvia miltiorrhiza (Danshen)

7 more in the full profile.

07

Biomarkers

Platelet aggregation rateTXB₂ (thromboxane B2) concentration6-keto-PGF1α (prostacyclin metabolite) concentrationHemorheological markers (e.g., blood viscosity)Null (no canonical drug target biomarker as for molecular receptors)

Beyond the preview

Go deeper on Blood circulation promotion via multi-herbal synergy in TCM theory.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood circulation promotion via multi-herbal synergy in TCM theory.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call